2010
Primary Merkel cell carcinoma of the parotid gland., Mahmoud Ghaderi, Jeffrey Coury, Jacqueline Oxenberg DO, and Harvey Spector (Article)
Cancer: The Lived Experience of Patients and Families, Lorraine Gyauch MA, RN,CT, CGS (Presentation)
Incorporating Rehabilitation Services into Oncology Site-specific Clinical Practice Guidelines, Kathleen Leies RN, OCN; Kathy Sevedge RN, MA, AOCN; Dorothy Morrone RNC, MS, OCN; Stephanie Marshall CCER; and Jennifer Roeder MSPT, MBA (Poster)
Immunologic Therapy with Cadi-05 for the Treatment of Advanced Melanoma, Paul J. Mosca MD, PhD; Suresh G. Nair MD; Susan K. Ayre RN, MA; Wenjing Shi RN, MS; Sherrine Eid MPH; Shantu Amin PhD; Dhimant Desai PhD; Joseph J. Drabick MD, FACP; Bakulesh M. Khamar MD; Arati Sharma PhD; Svetomir N. Markovic MD; and Gavin P. Robertson PhD (Poster)
Adjuvant mFOLFOX6 plus or minus cetuximab (Cmab) in patients (pts) with KRAS mutant (m) resected stage III colon cancer (CC): NCCTG Intergroup Phase III Trial N0147, Suresh G. Nair MD; Richard M. Goldberg; Daniel J. Sargent; Stephen N. Thibodeau; Margaret R. Mahoney; Anthony F. Sheilds; Emily Chan; Sharlene Gill; Morton S. Kahlenberg; and Steven R. Alberts MD, MPH (Presentation)
RB gene family: genome-wide ChIP approaches could open undiscovered roads., Flavio Rizzolio, Luca Esposito, Debora Muresu, Roberto S Fratamico MD, Ranna Jaraha, Gianluca Vosa Caprioli, and Antonio Giordano (Article)
Identification of Issues Faced by Cancer Survivors, Kathy Sevedge RN, MA, AOCN (Poster)
Patient Navigation: Past, Present and Future, Kathy Sevedge RN, MA, AOCN (Presentation)
2009
Training Tomorrow’s Providers and Expanding Access to Peginterferon/Ribavirin Combination Therapyfor Chronic Hepatatis C in Underinsured/Uninsured Patients: Final Outcomes of a Pilot, Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Suzanne J. Templer DO; Edward Norris MD, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding., Hongan Le, Sheetal Singh, Shyh-Jen Shih, Nga Du, Sabine Schnyder, Grace A Loredo, Christine Bien, Laura Michaelis, Amir Toor MD, Manuel O Diaz, and Andrew T Vaughan (Article)
Acute Splenic Infarct in Beta-Thalassemia Minor: A Novel Combination of Heterozygous Beta-Globin Mutations With Latent Phenotypes and the Clinical Implications, Danny C. Liaw, Adam J. Kotkiewicz, and Mark A. Kender (Article)
Activator protein-1 has an essential role in pancreatic cancer cells and is regulated by a novel Akt-mediated mechanism., Sonyo Shin, Takayuki Asano, Yixin Yao, Ronghua Zhang, Francois-Xavier Claret, Murray Korc, Kanaga Sabapathy, David G Menter, James L Abbruzzese, and Shrikanth A G Reddy (Article)
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same., Amir Toor MD (Article)
Impaired NHEJ function in multiple myeloma., Clara Yang, Christopher Betti, Sheetal Singh, Amir Toor MD, and Andrew Vaughan (Article)
2008
Psychiatric Outcomes in a Resident-Run Multidisciplinary Hepatitis C Clinic, Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases., Sheikh Asim Ali MD, Wassim M McHayleh, Asif Ahmad, Rajesh Sehgal, Molly Braffet, Mohsin Rahman, Ghassan Bejjani, and David M Friedland (Article)
Marginal-zone B-cell lymphoma of the bony palate presenting as sinusitis., Lisa Skultety Ayers, Jacqueline Oxenberg DO, Seth Zwillenberg, and Mahmoud Ghaderi (Article)
Can Surgeons Improve Survival in Stage IV Melanoma?, Paul J. Mosca MD, PhD; Erik J. Teicher MD; Suresh G. Nair MD; and Barbara A. Pockaj (Article)
Targeting Intracellular Signaling Pathways in Soft Tissue Sarcoma (STS)., Suresh G. Nair MD, Abhishek Sharma, and Amin S. Robertson (Poster)
Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT., Amir Toor MD, T Rodriguez, M Bauml, H Mathews, S Shanti, D Senitzer, A Kini, J Norton, M Parthasarathy, N Mohideen, C Petrowsky, B Bonilla, S Smith, and P Stiff (Article)
2007
Current Immunotherapeutic Strategies in Malignant Melanoma., Nicole Agostino DO; Arjumand Ali MD; Suresh G. Nair MD; and Paul J. Mosca MD, PhD (Article)
Outcomes of Peginterferon alfa-2a and Ribavirin Combination Therapy in a Resident-Initiated, Multidisciplinary, Hepatitis C Clinic, Nicole M. Agostino DO; Erini Vasiliadis DO; K Nadeem Ahmed MD; Suzanne J. Templer DO; Edward R. Norris MD, FAPA, FAPM; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Joseph L. Yozviak DO, FACP (Poster)
Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma., Henry C Fung, Patrick Stiff, Jeff Schriber, Amir Toor MD, Eileen Smith, Tulio Rodriguez, Amrita Krishnan, Arturo Molina, David Smith, Barbara Ivers, Neil Kogut, Leslie Popplewell, Roberto Rodriguez, George Somlo, Stephen J Forman, and Auayporn Nademanee (Article)
Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections., K Mullane, Amir Toor MD, C Kalnicky, T Rodriguez, J Klein, and P Stiff (Article)
Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activity., Amir Toor MD, Patrick J Stiff, Brian J Nickoloff, Tulio Rodriguez, Jared L Klein, and Kenneth B Gordon (Article)
Subcutaneous panniculitis-like T-cell lymphoma in a patient with long-term remission with standard chemotherapy., Haowei Zhang, Ranju Gupta MD, Jen C Wang, Jeffrey F Lipton, and Yi-Wu Huang (Article)
2006
Psychiatric Outcomes in a Resident-run, Multidisciplinary, Hepatitis C Clinic (Poster), Nicole M. Agostino DO; Edward Norris MD, FAPM; Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Charles M. Brooks MD; Eric J. Gertner MD, MPH; and Michael Kaufmann MD (Poster)
Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma., J Duus, H I Bahar, G Venkataraman, F Ozpuyan, K F Izban, H Al-Masri, T Maududi, Amir Toor MD, and S Alkan (Article)
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders., Ranju Gupta, Sirisha Perumandla, Yelena Patsiornik, Selvanayagam Niranjan, and Anju Ohri (Article)
A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer., Julian R. Molina, Daniel Nikcevich, Shauna L. Hillman, Susan Geyer, Timothy Drevyanko, James Jett, Joseph Verdirame, Henry Tazelaar, Kendrith M. Rowland, Edward Wos, Leila Kutteh, Suresh G. Nair MD, Tom R. Fitch, Patrick Flynn, Philip J. Stella MD, and Alex A. Adjei (Article)
Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma., Katherine E. Posther, M Angelica Selim, Paul J. Mosca, Wilma E. Stanley, Jeffrey L. Johnson, Douglas S. Tyler MD, and Hilliard F. Seigler MD (Article)
Cultural Compentency and Cancer, Debbie Salas-Lopez MD, MPH (Presentation)
The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failure., Scott E Smith, Amir Toor MD, Tulio Rodriguez, and Patrick Stiff (Article)
Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation., P J Stiff, L A Miller, P Mumby, K Kiley, R Batiste, N Porter, K Potocki, M Volle, S Lichtenstein, S Wojtowicz, S Zakrzewski, Amir Toor MD, and T Rodriguez (Article)
Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis., P Stiff, P Mumby, L Miler, T Rodriguez, M Parthswarthy, K Kiley, N Porter, R Batiste, S Wojtowitz, S Lichtenstein, M Fox-Geiman, and Amir Toor MD (Article)
Cardiac nonamyloidotic immunoglobulin deposition disease., Amir Toor MD, Ben A Ramdane, Jacob Joseph, Maria Thomas, Carl O'Hara, Bart Barlogie, Patrick Walker, and Lija Joseph (Article)
Expanding Access to Care through a Resident-Initiated Hepatitis C Clinic - An Innovative Method for Incorporating ACGME Core Competencies into the Management of Medically Underserved Patients, Joseph L. Yozviak DO, FACP; Suzanne J. Templer DO; Erini Vasiliadis DO; Vishal Patel MD; Nicole M. Agostino DO; K Nadeem Ahmed MD; Edward Norris MD, FAPM; Charles M. Brooks MD; and Eric J. Gertner MD, MPH (Poster)
2005
Oxaliplatin, Fluorouracil, and Leucovorin for Patients with Unresectable Liver-Only Metastases from Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study., Steven R. Alberts MD, MPH; William L. Horvath; William C. Sternfeld; Richard M. Goldberg; Michelle R. Mahoney; Shaker R. Dakhil MD; Ralph Levitt MD; Kendrith M. Rowland; Suresh G. Nair MD; Daniel J. Sargent; and John H. Donohue (Article)
Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response., Thomas A. Aloia MD; Elizabeth Grubbs MD; Mark Onaitis MD; Paul J. Mosca MD, PhD; Tsung-Yen Cheng MD; Hilliard F. Seigler MD; and Douglas S. Tyler MD (Article)
Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells., Takayuki Asano, Yixin Yao, Sonyo Shin, James McCubrey, James L Abbruzzese, and Shrikanth A G Reddy (Article)
Perceived Quality of Life Among Smokers in Smoking Cessation Therapy., I Croghan, Jeff A. Sloan, R D. Hurt, G A. Croghan, Shaker R. Dakhil MD, Paul J. Novotny, D Schroeder, Edward J. Wos, Kendrith M. Rowland, and Suresh G. Nair MD (Article)
Second allografts for relapsed hematologic malignancies: feasibility of using a different donor., J E Duus, P J Stiff, J Choi, M Parthasarathy, T Rodriguez, and Amir Toor MD (Article)
Tuberculosis of sacroiliac joint: an unusual presentation., Ranju Gupta MD, Harry Bienenstock, Placido Morano, and Anil Gupta (Article)
Should Elderly Non-Small-Cell Lung Cancer Patients be Offered ElderlySpecific Trials? Results of a Pooled Analysis from the North Central Cancer Treatment Group., Aminah Jatoi, Shauna L. Hillman, Philip J. Stella MD, Erin Green, Alex A. Adjei, Suresh G. Nair MD, Edith A. Perez MD, Bipinkur Amin, Steven E. Schild, Rene Castillo, and James R. Jett (Article)
Hepatocellular carcinoma in an African American man with a noncirrhotic liver presented initially as an occipital mass., Maged Khalil MD, Padjama Sai, Zili He, Ashraf Aziz, William Steier, Shetra Sivamurthy, Ming Liu, and Madhumati Kalavar (Article)
Epithelioid Angiosarcoma of the Small Intestine After Occupational Exposure to Radiation and Polyvinyl Chloride: A case Report and Review of Literature., Maged Khalil MD, Asha Thomas, Adel Aassad, Moshe Rubin, and Robert N Taub (Article)
Randomized Phase II Trial of Three Schedules of Pemetrexed and Gemcitabine as Front-Line Therapy for Advanced Non-Small-Cell Lung Cancer., Cynthia X Ma, Suresh G. Nair MD, Sachdev Thomas, Sumithra J. Mandrekar, Daniel A. Nikcevich, Kendrith M. Rowland, Tom R. Fitch MD, Harold E. Windschitl, Shauna L. Hillman, Steven E. Schild, James R. Jett, Coleman Obasaju, and Alex A. Adjei (Article)
Factors that Influence Colorectal Cancer Screening Practice in the Latino Community, Ana Natale-Pereira MD, MPH; Marielos Vega RN, BSN; Jonnie Marks PhD; Debbie Salas-Lopez MD, MPH; and M S. Johnson (Presentation)
Perspectives on Cancer Screening Among Internal Medicine Residents and Latino Community Members: A Work in Progress, Debbie Salas-Lopez MD, MPH; Dawne M. Mouzon MPH; Ana Natale-Pereira MD, MPH; Vincent J. Barba; John Kolassa; Jonnie Marks PhD; and Maria L. Soto-Greene MD (Presentation)
2004
Gemcitabine and ISIS-2503 for Patients with Locally Advanced or Metastatic Pancreatic Adenocarcinoma: A North Central Cancer Treatment Group Phase II Trial., Steven R. Alberts MD, MPH; Mark Schroeder; Charles Erlichman; Preston D. Steen MD; Nathan R. Foster; Dennis F. Moore; Kendrith M. Rowland; Suresh G. Nair MD; Loren K. Tschetter; and Tom R. Fitch MD (Article)
Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines., Christiane Houde, Yulin Li, Lynda Song, Kevin Barton, Qing Zhang, John Godwin, Sucha Nand, Amir Toor MD, Serhan Alkan, N Veronique Smadja, Hervé Avet-Loiseau, Carmen S Lima, Lucio Miele, and Lionel J Coignet (Article)
Investigating Four 'Myths' Surrounding Dysphagia in Patients with Metastatic Esophageal Cancer. A Multi-Institutional Study from the North Central Cancer Treatment Group., Aminah Jatoi, Nathan R. Foster, P Johnson, George G. Klee, J F Quevedo, Roscoe F. Morton MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James A. Mailliard MD (Article)
An Eicosapentaenoic Acid Supplement Versus Megestrol Acetate Versus Both for Patients with Cancer-Associated Wasting: A North Central Cancer Treatment Group and National Cancer Institute of Canada Collaborative Effort., Aminah Jatoi, Kendrith M. Rowland, Charles L. Loprinzi, Jeff A. Sloan, Shaker R. Dakhil MD, Neil MacDonald, Bruno Gagnon, Paul J. Novotny, James A. Mailliard MD, Teresita I L Bushey, Suresh G. Nair MD, and Brad Christensen (Article)
Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity., Anne Kanard, Aminah Jatoi, Rene Castillo, Susan Geyer, Thomas K. Schulz, Tom R. Fitch MD, Kendrith M. Rowland, Suresh G. Nair MD, James E. Krook MD, and John W. Kugler MD (Article)
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis., Maged Khalil MD, William D Wagner, and Ira J Goldberg (Article)
Phase II Evaluation of 96-Hour Paclitaxel Infusion in Advanced (Recurrent or Metastatic) Squamous Cell Carcinoma of the Head and Neck (E3395): a Trial of the Eastern Cooperative Oncology Group., Corey J. Langer, Yi Li, Timothy Jennings, Ronald C. DeConti, Suresh G. Nair MD, Roger B. Cohen, and Arlene A. Forastiere (Article)
Post-transplant air-leak syndrome., Tawee Tanvetyanon, Amir Toor MD, and Patrick J Stiff (Article)
Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myeloma., Amir Toor MD, John Ayers, Joan Strupeck, Mala Parthasarathy, Steve Creech, Tulio Rodriguez, and Patrick J Stiff (Article)
2003
BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective., Julian P Cooney, Patrick J Stiff, Amir Toor MD, and Mala Parthasarathy (Article)
Infection--an underappreciated cause of bone pain in multiple myeloma., Raman Desikan, Bart Barlogie, Rajesh Sethi, Amir Toor MD, Dan Spoon, Edward Angtuaco, Rudy Vanhemert, Anantha VijayaGopal, Seema Singhal, Jayesh Mehta, Sundar Jagannath, Nikhil Munshi, Maurizio Zangari, Athanassios Fassas, Guido Tricot, and Elias Anaissie (Article)
Impact of Immediate Reconstruction on the Local Recurrence of Breast Cancer After Mastectomy., Robert X. Murphy JR, MD, MS; Samina Wahhab MD; Peter Rovito MD; Gregory R. Harper MD, PhD; Sharon R. Kimmel; Lawrence C. Kleinman MD, MPH; and Mark J. Young MD (Article)
2002
CPT-11 for Bile-Duct and Gallbladder Carcinoma: A Phase II North Central Cancer Treatment Group (NCCTG) Study., Steven R. Alberts MD, MPH; Paul A. Fishkin; Lawrence J. Burgart; Peter J. Cera; Michelle R. Mahoney; Roscoe F. Morton MD; Patricia A. Johnson; Suresh G. Nair MD; and Richard M. Goldberg (Article)
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning., Ashraf Badros, Guido Tricot, Amir Toor MD, Christopher Morris, Chuanfa Guo, Nikhil Munshi, Bart Barlogie, and Michele Cottler-Fox (Article)
Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations., Athanasios B-T Fassas, Firas Muwalla, Tanya Berryman, Riad Benramdane, Lija Joseph, Elias Anaissie, Rajesh Sethi, Raman Desikan, David Siegel, Ashraf Badros, Amir Toor MD, Maurizio Zangari, Christopher Morris, Edgardo Angtuaco, Sajini Mathew, Carla Wilson, Aubrey Hough, Sami Harik, Bart Barlogie, and Guido Tricot (Article)
Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients with Colon Carcinoma: A 10-Year Experience of the Geisinger Medical Center., Farid Fata, Ayoub Mirza, G Craig, Suresh G. Nair MD, Amy Law, James Gallagher, Neil Ellison, and Albert M. Bernath MD (Article)
A Phase II Trial of Docetaxel and CPT-11 in Patients with Metastatic Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia., Aminah Jatoi; Marisa Tria Tirona; Steven S. Cha; Steven R. Alberts MD, MPH; Kendrith M. Rowland; Roscoe F. Morton MD; Suresh G. Nair MD; Carl G. Kardinal MD; Philip J. Stella MD; James A. Mailliard MD; Daniel J. Sargent; and Richard M. Goldberg (Article)
Microscale assay for screening of inhibitory activity of Lactobacillus., Bradley Lash, Hassan Gourama, and Tami H Mysliwiec (Article)
Long-Term Survival of Patients with Advanced/Recurrent Carcinoma of Cervix and Vagina After Neoadjuvant Treatment with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with or without the Addition of Molgramostim, and Review of the Literature., Harry J. Long, Sandra Rayson, Karl C. Podratz, Samir Abu-Ghazaleh, Vera J. Suman PhD, Lynn C. Hartmann MD, Ralph Levitt MD, Suresh G. Nair MD, Alan K. Hatfield MD, and James A. Knost (Article)
A phase II study of Paclitaxel and Cisplatin for Extensive Stage Small Cell Lung Cancer., Randolph S. Marks MD and Suresh G. Nair MD (Article)
Clinical activity of arsenic trioxide for the treatment of multiple myeloma., N C Munshi, G Tricot, R Desikan, A Badros, M Zangari, Amir Toor MD, C Morris, E Anaissie, and B Barlogie (Article)
Women Experience Greater Toxicity with Fluorouracil-Based Chemotherapy for Colorectal Cancer., Jeff A. Sloan, Richard M. Goldberg, Daniel J. Sargent, Delfino Vargas-Chanes, Suresh G. Nair MD, Steven S. Cha, Paul J. Novotny, Michael A. Poon, Michael J. O'Connell, and Charles L. Loprinzi (Article)
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients., Amir Toor MD, A Slungaard, U Hedner, D J Weisdorf, and N S Key (Article)
Predicting long-term (> or = 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants., Guido Tricot, Trey Spencer, Jeffrey Sawyer, Dan Spoon, Raman Desikan, Athanasios Fassas, Ashraf Badros, Maurizio Zangari, Nikhil Munshi, Elias Anaissie, Amir Toor MD, and Bart Barlogie (Article)
Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications., M Zangari, F Saghafifar, E Anaissie, A Badros, R Desikan, A Fassas, P Mehta, C Morris, Amir Toor MD, D Whitfield, E Siegel, B Barlogie, L Fink, and G Tricot (Article)
2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions., A Badros, B Barlogie, C Morris, R Desikan, S R Martin, N Munshi, M Zangari, J Mehta, Amir Toor MD, M Cottler-Fox, A Fassas, E Anaissie, S Schichman, and G Tricot (Article)
Images in clinical medicine. Bilateral ovarian dermoid cysts., Richard Boulay MD and E Podczaski (Article)
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone., K R Desikan, G Tricot, N C Munshi, E Anaissie, D Spoon, A Fassas, Amir Toor MD, M Zangari, A Badros, C Morris, D H Vesole, D Siegel, S Jagannath, and B Barlogie (Article)
T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells., Amir Toor MD, T C Lund, and J S Miller (Article)
Infections during mobilizing chemotherapy and following autologous stem cell transplantation., Amir Toor MD, J A van Burik, and D J Weisdorf (Article)
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy., M Zangari, E Anaissie, B Barlogie, A Badros, R Desikan, A V Gopal, C Morris, Amir Toor MD, E Siegel, L Fink, and G Tricot (Article)
2000
A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas., Patrick A. Burch MD, Albert M. Bernath MD, Terrence L. Cascino, Bernd W. Scheithauer MD, Paul Novotny, Suresh G. Nair MD, Jan C. Buckner, Delano M. Pfeifle, John W. Kugler MD, and Loren K. Tschetter (Article)
A Phase II Study of Paclitaxel Plus Carboplatin as First-Line Chemotherapy for Women with Metastatic Breast Carcinoma., Edith A. Perez MD, David W. Hillman MS, Philip J. Stella MD, James E. Krook MD, Lynn C. Hartmann MD, Tom R. Fitch MD, Alan K. Hatfield MD, James A. Mailliard MD, Suresh G. Nair MD, Carl G. Kardinal MD, and James N. Ingle MD (Article)
A Randomized Phase II and Pharmacokinetic Study of Dacarbazine in Patients with Recurrent Glioma., S. Vincent Rajkumar MD, Joel M. Reid, Paul J. Novotny, Stephanie L. Safgren, Bernd W. Scheithauer MD, P. Steven Johnson, Suresh G. Nair MD, Roscoe F. Morton MD, Alan K. Hatfield MD, James E. Krook MD, Matthew M. Ames, and Jan C. Buckner (Article)
Sex Differences in Fluorouracil-Induced Stomatitis., Jeff A. Sloan, Charles L. Loprinzi, Paul J. Novotny, Scott H. Okuno MD, Suresh G. Nair MD, and Debra L. Barton (Article)
Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation., Amir Toor MD, S Y Choo, and J A Little (Article)
1999
Alleviation of Gastrointestinal Mucosal Toxicity Related to Chemotherapy and Radiation Therapy: The NCCTG Experience., Scott H. Okuno MD, T Kozelsky, Charles L. Loprinzi, and Suresh G. Nair MD (Article)
Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma., S. Vincent Rajkumar MD, Patrick A. Burch MD, Suresh G. Nair MD, Robert P. Dinapoli MD, Bernd W. Scheithauer MD, Judith R. O'Fallon MD, Paul S. Etzell MD, John M. Leitch MD, Roscoe F. Morton MD, and Randolph S. Marks MD (Article)
1998
Combined Levamisole with Recombinant Interleukin-2 (IL-2) in Patients with Advanced Renal Cell Carcinoma: A Phase II Study., Edward T. Creagan MD, Robert D. Hestorff, Vera J. Suman PhD, James A. Mailliard MD, Suresh G. Nair MD, James E. Krook MD, John W. Kugler MD, Robert F. Marschke, John C. Michalak, and Loren K. Tschetter (Article)
Cloning, expression, and characterization of a novel guanylate-binding protein, GBP3 in murine erythroid progenitor cells., B H Han; Don J. Park MD, PhD; R W Lim; J H Im; and H D Kim (Article)
Phase II Trial of Topotecan for the Treatment of Mesothelioma., Andrew W. Maksymiuk, Robert F. Marschke, Henry D. Tazelaar, Joe Grill, Suresh G. Nair MD, Randolph S. Marks MD, B. Jay Brooks, James A. Mailliard MD, G. Mark Burton, and James R. Jett (Article)
Primary Small Cell Anaplastic Carcinoma of the Breast Diagnosed by Fine Needle Aspiration Cytology: A Case Report., Matjaz Sebenik MD, Suresh G. Nair MD, and Husam F. Hamati MD (Article)
1997
Folate deficiency delays the onset but increases the incidence of leukemia in Friend virus-infected mice., M J Koury; Don J. Park MD, PhD; D Martincic; D W Horne; V Kravtsov; J A Whitlock; M del Pilar Aguinaga; and P Kopsombut (Article)
1996
Delayed Presentation of Breast Masses and Subsequent Treatment Compliance., Peggy E. Chatham-Showalter MD, Stephanie Knabbe, and Nora Suggs MD (Presentation)
Concurrent 72-hour continuous infusion of etoposide and cisplatin in metastatic breast cancer., S C Remick, M Chmura, C Bromberg, J Sporn, B Healey, J Hilstro, R C DeConti, J Horton, J C Ruckdeschel, and G R Harper (Article)
1995
Encouraging mammography use among underserved women through a celebration of breast health., B H Englisbe; G E Jimpson; Gregory R. Harper MD, PhD; and M Cohen (Article)
Pilot Study of Human Recombinant Interferon Gamma and Accelerated Hyperfractionated Thoracic Radiation Therapy in Patients with Unresectable Stage IIIA/B Nonsmall Cell Lung Cancer., Edward G. Shaw MD, Richard L. Deming MD, Edward T. Creagan MD, Suresh G. Nair MD, John Q. Su PhD, Ralph Levitt MD, Preston D. Steen MD, Martin Wiesenfeld MD, and James A. Mailliard MD (Article)
1994
Induction of Squamous Differentiation by Interferon Beta in a Human Non-Small-Cell Lung Cancer Cell Line., Suresh G. Nair MD, Jane E. Mayotte, Anna Lokshin, and Mark L. Levitt (Article)
1993
Rapid induction of mouse virus-like (VL30) element transcripts by erythropoietin in murine erythroid progenitor cells., Don J. Park MD, PhD; R W Lim; and H D Kim (Article)
1992
Immunological Effects of Treatment with Sequential Administration of Recombinant Interferon Gamma and Alpha in Patients with Metastatic Renal Cell Carcinoma During a Phase I Trial., Marc S. Ernstoff MD, William Gooding, Suresh G. Nair MD, Robert R. Bahnson MD, Linda M. Miketic, Barbara Banner, Roger Day, Theresa Whiteside, Linda Titus-Ernstoff, and John M. Kirkwood MD (Article)
Interferon-Induced Reversible Acute Renal Failure with Nephrotic Syndrome., Suresh G. Nair MD, Marc S. Ernstoff MD, Robert R. Bahnson MD, Sam Arthur MD, James Johnston MD, Mary Ann Downs RN, Julie Neuhart RN, and John M. Kirkwood MD (Article)